European Archives - Page 364 of 1188 - European Medical Journal

Prostate Cancer and Partners: Addressing Unmet Sexual Needs

A team of researchers has created a new tool to assess the sexual health of female partners of patients with prostate cancer

Unravelling Pancreatitis in Youth: Study Findings

Supportive care is the main approach when it comes to treating acute pancreatitis. Retrospective studies of the causes and characteristics of hospitalised patients can help pinpoint and eliminate potential triggers…

High HbA1c Levels Associated with Poor Asthma Control in Children

A new study has found that high HbA1c levels, consistent with pre-diabetes, are linked to poor asthma control in paediatric patients

Immunotherapy and Biologics Show Promise for IgE-Mediated Food Allergies

A study reveals promising results for managing IgE-mediated food allergies with immunotherapy and biologics

Melanoma – An Inherited Cancer?

According to a recent study from the Cleveland Clinic, genes may play a significantly larger role in melanoma risk than previously believed

Diabetes-Related Dementia Risk Elevated by Atherosclerotic Cardiovascular Disease

A study of over 103,000 patients reveals that diabetes with coronary artery disease significantly increases the risk of dementia, especially vascular dementia.

Heavy Menstrual Bleeding Increases Heart Disease Risk

Research shows heavy menstrual bleeding, a common menstrual disorder, has been linked to several multiple risk factors of cardiovascular disease in females

Early Blood Glucose Control Can Minimise Diabetes-Related Complications

Intensive control of blood glucose early on can minimise the lifetime risk of diabetes-related complications, if managed early enough.

Point-of-Care Testing Versus Traditional Methods for Infliximab Monitoring

Infliximab (IFX) is increasingly the prescribed therapy for chronic inflammatory bowel disease in paediatric patients. Successful treatment with IFX is dependent on numerous factors…

Picture of a pink illustrated brain on a mint green background

Elon Musk’s Neuralink seeks patients for clinical trial

Neuralink, Elon Musk’s brain chip company, is preparing for the first clinical trial of its implant technology.